Abstract: According to one embodiment, method of identifying feature of test body is provided. The method includes measuring a mutation-specific concentration of at least one miRNA contained in the test body, correcting a value of the mutation-specific concentration, and determining whether the test body is a cancer or a non-cancer one using an increase or decrease in the corrected mutation-specific concentration as index.

Abstract: An analysis method may determine the presence of affection of at least any one of breast cancer, pancreatic cancer, lung cancer, gastric cancer, and colorectal cancer. The analysis method may include quantifying at least any one of hsa-miR-205-5p, hsa-miR-30e-5p, hsa-miR-106b-5p, hsa-miR-3613-5p, hsa-miR-483-5p, hsa-miR-574-3p, hsa-miR-125b-5p, hsa-miR-223-5p, hsa-miR-3613-3p, hsa-miR-941, hsa-miR-324-3p, hsa-miR-193a-5p, hsa-miR-4433a-3p, hsa-miR-29c-3p, hsa-miR-190a-5p, hsa-miR-885-5p, hsa-miR-194-5p, hsa-miR-29a-3p, hsa-miR-142-5p, hsa-miR-142-3p, hsa-miR-122-5p, hsa-miR-34a-5p, and hsa-miR-375-3p in a sample derived from an object.

Abstract: According to one embodiment, a method for analyzing the probability of suffering from cancer in a subject is provided. The method includes counting the number of types of RNA in a sample derived from the subject with respect to the types of RNAs in which sequence variation based on RNA editing exists in comparison with a reference sequence, and determining the probability of suffering from cancer in the subject by using the number of types of RNAs obtained as an index.

Abstract: Disclosed is a novel measure that is effective in therapy etc. of psychiatric or neurological disorders or symptoms, such as anxiety or depressive disorders, and is unlikely to cause problems such as dependence and adverse effects and is highly safe. The present invention provides an agent for treating, preventing, or ameliorating psychiatric or neurological disorders or symptoms, wherein the agent contains any of the followings as an active ingredient: (1) disulfiram, (2) a metal complex of diethyldithiocarbamate, (3) a disulfide capable of generating diethyldithiocarbamate in the body, (4) a pharmaceutically acceptable salt of (1), (2), or (3), and (5) a solvate of (1), (2), (3), or (4).

Abstract: A data read apparatus which, when reading data in a data region sequentially, consults information pieces indicative of positions of information pieces concerning files to identify a position of an information piece concerning a file corresponding to a data piece at a reading position, consults an information piece concerning the file at the identified position to calculate an output position in a temporary memory region to which the data is to be outputted, delivers the data read out of an area in the data region to the output position, decides whether files corresponding to outputted data are all present in the temporary memory region and delivers the files to a backup region in a unit of file when the presence of all files is determined.

Abstract: A data read apparatus which, when reading data in a data region sequentially, consults information pieces indicative of positions of information pieces concerning files to identify a position of an information piece concerning a file corresponding to a data piece at a reading position, consults an information piece concerning the file at the identified position to calculate an output position in a temporary memory region to which the data is to be outputted, delivers the data read out of an area in the data region to the output position, decides whether files corresponding to outputted data are all present in the temporary memory region and delivers the files to a backup region in a unit of file when the presence of all files is determined.